| Name | Lewis Drug # 12 |
|---|---|
| Organization Name | Lewis Drugs Inc |
| Location | 910 22nd Ave S, Brookings, South Dakota 57006 |
| Type | Pharmacy |
| Phone | (605) 692-8881 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Combining the therapeutic potential and advantages of existing oligonucleotide-based approaches to turn off disease-related genes, a type of single-stranded silencing RNAs (ss-siRNAs) has shown significantly improved potency and activity.
A study in the Aug. 1 issue of the journal Sleep shows that at 2 to 4 weeks of age male infants are easier to arouse than females during quiet sleep, and by 2 to 3 months of age there are no significant gender differences in arousability. The results suggest that the increased rate of sudden infant death syndrome (SIDS) in males may not reflect a pre-existing vulnerability involving arousal responses.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the North American Spine Society (NASS) has issued their formal coverage recommendation for MIS SI joint fusion titled "Percutaneous Sacroiliac Joint Fusion, Defining Appropriate Coverage Positions."
› Verified 5 days ago
| NPI Number | 1437248051 |
| Organization Name | LEWIS DRUGS, INC. |
| Doing Business As | LEWIS DRUG BROOKINGS |
| Type | Pharmacy |
| Address | 910 22nd Ave S, Brookings, SD 57006 |
| Phone Number | 605-692-8881 |
News Archive
Combining the therapeutic potential and advantages of existing oligonucleotide-based approaches to turn off disease-related genes, a type of single-stranded silencing RNAs (ss-siRNAs) has shown significantly improved potency and activity.
A study in the Aug. 1 issue of the journal Sleep shows that at 2 to 4 weeks of age male infants are easier to arouse than females during quiet sleep, and by 2 to 3 months of age there are no significant gender differences in arousability. The results suggest that the increased rate of sudden infant death syndrome (SIDS) in males may not reflect a pre-existing vulnerability involving arousal responses.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the North American Spine Society (NASS) has issued their formal coverage recommendation for MIS SI joint fusion titled "Percutaneous Sacroiliac Joint Fusion, Defining Appropriate Coverage Positions."
› Verified 5 days ago
News Archive
Combining the therapeutic potential and advantages of existing oligonucleotide-based approaches to turn off disease-related genes, a type of single-stranded silencing RNAs (ss-siRNAs) has shown significantly improved potency and activity.
A study in the Aug. 1 issue of the journal Sleep shows that at 2 to 4 weeks of age male infants are easier to arouse than females during quiet sleep, and by 2 to 3 months of age there are no significant gender differences in arousability. The results suggest that the increased rate of sudden infant death syndrome (SIDS) in males may not reflect a pre-existing vulnerability involving arousal responses.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the North American Spine Society (NASS) has issued their formal coverage recommendation for MIS SI joint fusion titled "Percutaneous Sacroiliac Joint Fusion, Defining Appropriate Coverage Positions."
› Verified 5 days ago
Walmart Pharmacy 10-1538 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2233 6th St, Brookings, South Dakota 57006 Phone: (605) 692-1858 | |
Hy-vee Pharmacy 1039 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 790 22nd Ave S, Brookings, South Dakota 57006 Phone: (605) 692-7311 | |
Lewis Drug # 12 Type: Pharmacy Location: 910 22nd Ave S, Brookings, South Dakota 57006 Phone: (605) 692-8881 | |
Brothers Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1004 6th St, Brookings, South Dakota 57006 Phone: (605) 692-2088 | |
Brothers Pharmacy Ltc Type: Medicare Supplier Location: 1004 6th St, Brookings, South Dakota 57006 Phone: (605) 696-3526 |